StockData
Novartis AG logo

Novartis AG (NVS) stock

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.20−0.30 (-0.19%)

Close on Nov 16, 2026Market cap $305.69BP/E 22.4Yield –

Novartis price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Novartis's price to book ratio was 7.7× on Nov 10, 2026, against 6.3× a year earlier. Over the last 5 years it ranged from 2.7× to 7.7×, with a median of 4.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 10, 20267.7×+1.0
2025Dec 31, 20256.7×+1.8
2024Dec 31, 20244.9×+0.6
2023Dec 29, 20234.3×+1.0
2022Dec 30, 20223.3×−0.5
2021Dec 31, 20213.7×−0.4
2020Dec 31, 20204.1×−0.2
2019Dec 31, 20194.3×+1.7
2018Dec 31, 20182.6×−0.1
2017Dec 29, 20172.7×–

More Novartis figures

See a number that looks wrong?